论文部分内容阅读
1998年8月～1999年7月我们采用苦参碱静点治疗肝炎后肝硬化失代偿期肝功能异常患者30例,经与对照组比较,疗效较好,现报告如下。 1 一般资料 将全部55例患者随机分为两组。观察组30例,其中男21例,女9例,年龄36～75岁。对照组25例,其中男18例,女7例,年龄33～70岁。所有病例均有不同程度的腹胀、纳差、乏力、肝区不适等临床症状。两组在病情程度、临床表现、年龄、性别等方面经统计学处理,无显著差异,具有可比性(P>0.05)。55例患者中42例既往有明确的慢性肝炎病史。全部患者血清HBsAg、HBVDNA均为阳性。所有病例根据其临床表现及B超、CT检查,明确了肝硬化失代偿期的诊断。55例患者中,有47例血清ALT高于正常,平均
August 1998 ~ July 1999 we use matrine static point treatment of liver cirrhosis patients with decompensated liver dysfunction in 30 patients, compared with the control group, the effect is better, are as follows. 1 General Information All 55 patients were randomized into two groups. The observation group of 30 cases, including 21 males and 9 females, aged 36 to 75 years. Control group of 25 patients, 18 males and 7 females, aged 33 to 70 years. All cases have varying degrees of abdominal distension, anorexia, fatigue, liver discomfort and other clinical symptoms. The two groups in the disease severity, clinical manifestations, age, gender and other aspects of the statistical treatment, no significant difference, comparable (P> 0.05). Of the 55 patients, 42 had a history of a definite history of chronic hepatitis. All patients serum HBsAg, HBVDNA were positive. All cases based on their clinical manifestations and B ultrasound, CT examination, a clear diagnosis of decompensated liver cirrhosis. Of the 55 patients, 47 had serum ALT higher than normal and mean